Monday, February 25, 2019; 1:00 PM - 3:00 PM
Section outline
-
Lecture: Onchocerciasis and Article(s) review and discussion
Faculty: Jeremy Keenan
Location: Mission Hall 1109
-
Unnasch TR, Golden A, Cama V, Cantey PT. Diagnostics for onchocerciasis in the era of elimination. Int Health. 2018;10(suppl_1):i20-i26. File
-
Kamgno J et al. A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas. N Engl J Med. 2017;377(21):2044-2052. File
-
Lont YL, et al. Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes. PLoS Negl Trop Dis. 2017;11(1):e0005314. File
-
Opoku et al. A. Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial. Lancet. 2018;392(10154):1207-1216. File
-
Walker M, Stolk WA, Dixon MA, Bottomley C, Diawara L, Traoré MO, de Vlas SJ, Basáñez MG. Modelling the elimination of river blindness using long-term epidemiological and programmatic data from Mali and Senegal. Epidemics. 2017;18:4-15. File